The AIDS Vaccine Conference provides a unique opportunity to bring together the most experienced scientists in the field of HIV vaccine and to review the most recent advances in basic clinical science. It will emphasize the topics of therapeutic vaccines and the role of developing countries in the research for HIV vaccines.
This scientific meeting will bring together more than 1200 researchers from all over the world active in the field of AIDS vaccines. Vaccine developers, designers, epidemiologists, public health specialists, representatives from the pharmaceutical industry, and clinicians will share their experience and join their efforts to plan the most effective future vaccine strategies.
Location
Lausanne, Switzerland
Event Type
Conference
Dates
08/30/2004 - 09/01/2004
Sponsor
AIDS Vaccine 2004.
Contact
For more information, contact AIDS Vaccine 2004, Administrative Secretariat, c/o AKM Congress Service, PO Box 4005 Basel, Switzerland; by calling ++41 61 686 77 11; by faxing ++41 61 686 77 88; by e-mailing: aids2004@akm.ch; or by accessing the website: www.aidsvaccine04.org. A detailed programme for AIDS Vaccine 2004 is available on the website: www.aidsvaccine04.org/programme_conf.php.
Notes
The registration fee is $490 if paid before June 18th; $600 from June 19th to August 6th; and $700 for on-site registration or from August 7th, 2004. A limited number of travel grants and scholarships will be awarded to young scientists presenting an abstract or coming from a developing country. Abstract submission deadline is May 5th, 2004.
Subjects
Developing Nations Therapeutic Drugs Vaccine Development Research Vaccines
Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.
